Antonio Hernández Madrid

Antonio Hernández Madrid

Auto-generated profile, based on publicly available information

Antonio Hernández Madrid

Arrhythmia Unit, Cardiology Department, Ramón y Cajal Hospital, Alcalá University, Madrid, Spain

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in EP Europace
Verified
Journal Article
Closed access
PDF file
AHAntonio Hernández-Madrid
Antonio Hernández-Madrid
TPThomas Paul
Thomas Paul
DADominic Abrams
Dominic Abrams
PAPeter F Aziz
Peter F Aziz
NBNico A Blom
Nico A Blom
ADAnne Dubin
Anne Dubin
The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.

4 November 2016 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
LMLluís Mont
Lluís Mont
APAntonio Pelliccia
Antonio Pelliccia
SSSanjay Sharma
Sanjay Sharma
ABAlessandro Biffi
Alessandro Biffi
MBMats Borjesson
Mats Borjesson
MPMassimo Piepoli
Massimo Piepoli
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.

21 February 2016 in EP Europace
Verified
Journal Article
Closed access
PDF file
AMAntonio Hernández Madrid
Antonio Hernández Madrid
TPTatjana S. Potpara
Tatjana S. Potpara
NDNikolaos Dagres
Nikolaos Dagres
JCJian Chen
Jian Chen
TLTorben B. Larsen
Torben B. Larsen
CBCarina Blomstrom-Lundqvist
Carina Blomstrom-Lundqvist
The purpose of this patient survey was to analyse the knowledge about blood thinning medications relative to gender, age, education, and region of residence in patients with atrial fibrillation (AF). A total of 1147 patients with AF [mean age 66 ± 13 years, 529 (45%) women] from eight European countries responded to this survey. Most patients understood that the indication for anticoagulation therapy was to ‘thin the blood’, but 8.1% responded that the purpose of the medication was to treat the arrhythmia. Patients with college or university grades reported less frequent deviations from their target INR range compared with those without schooling (2.8% vs. 5.1%, P < 0.05). The awareness of anticoagulation-related risk of bleedings was lowest in patients without schooling (38.5%) and highest in those with college and university education (57.0%), P < 0.05. The same pattern was also observed regarding patient's awareness of non-vitamin K antagonist oral anticoagulants (NOACs): 56.5% of the patients with university education and only 20.5% of those without schooling (P < 0.05) knew about NOACs, indicating that information about new anticoagulation therapies remains well below the target. Bleeding events were statistically less frequent in patients on NOACs compared with vitamin K antagonists. The education level and patients' knowledge have a direct influence on the global management of the anticoagulation.

1 February 2016 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Open access
SPSilvia G. Priori
Silvia G. Priori
CBCarina Blomström-Lundqvist
Carina Blomström-Lundqvist
Andrea MazzantiAndrea Mazzanti
Andrea Mazzanti
NBNico Blom
Nico Blom
MBMartin Borggrefe
Martin Borggrefe
DVDirk J. Van Veldhuisen
Dirk J. Van Veldhuisen

4 November 2016 in EP Europace
Verified
Journal Article
Open access
PDF file
LMLluís Mont
Lluís Mont
APAntonio Pelliccia
Antonio Pelliccia
SSSanjay Sharma
Sanjay Sharma
ABAlessandro Biffi
Alessandro Biffi
MBMats Borjesson
Mats Borjesson
MPMassimo Piepoli
Massimo Piepoli
Exercise and sport in HCM patients. In most series, primarily from the U.S., HCM is the most common cause of SCD in young individuals engaged in competitive spo

16 December 2013 in EP Europace
Verified
Journal Article
Open access
PDF file
AHAntonio HernáNdez-Madrid
Antonio HernáNdez-Madrid
TLThorsten Lewalter
Thorsten Lewalter
APAlessandro Proclemer
Alessandro Proclemer
LPLaurent Pison
Laurent Pison
GLGregory Y.H. Lip
Gregory Y.H. Lip
CBCarina Blomstrom-Lundqvist
Carina Blomstrom-Lundqvist
The aim of this European Heart Rhythm Association survey was to provide an insight into the current use of remote monitoring for cardiac implantable electronic devices in Europe. The following topics were explored: use of remote monitoring, infrastructure and organization, patient selection and benefits. Centres using remote monitoring reported performing face-to-face visits less frequently. In many centres (56.9%), a nurse reviews all the data and forwards them to the responsible physician. The majority of the centres (91.4%) stated that remote monitoring is best used in patients with implantable cardioverter-defibrillators and those live far from the hospital (76.6% top benefit). Supraventricular and ventricular arrhythmias were reported to be the major events detected earlier by remote monitoring. Remote monitoring will have a significant impact on device management.